A potent adjuvant effect of CD40 antibody attached to antigen

Barr, T.A., Mccormick, A.L., Carlring, J. and Heath, A.W. (2003) A potent adjuvant effect of CD40 antibody attached to antigen. Immunology, 109(1), pp. 87-92. (doi:10.1046/j.1365-2567.2003.01634.x)

Full text not currently available from Enlighten.


There is great potential for novel vaccines based on recombinant proteins and synthetic peptides. Unfortunately these antigens often lack the immunogenicity of whole, killed pathogens used in traditional vaccines. Thus there is strong interest in the identification of immunological adjuvants with low reactogenicity, but high potency, to enhance immune responses and realize the potential of these new vaccine strategies. CD40 antibodies have been shown to have adjuvant effects when administered at very high doses. These large doses are impractical and induce a cascade of cytokine release giving rise to septic shock-like symptoms, as well as splenomegaly and polyclonal antibody production. We show here that a very small amount of CD40 antibody can exhibit potent adjuvant effects when attached to soluble antigen. The lack of detectable systemic effects indicates that this method may be a powerful and practical means of enhancing the efficacy of recombinant vaccines.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Barr, Dr Tom
Authors: Barr, T.A., Mccormick, A.L., Carlring, J., and Heath, A.W.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Immunology

University Staff: Request a correction | Enlighten Editors: Update this record